← FDA Drug Approvals (Drugs@FDA)

PRANDIN

NDA · New Drug Application · Sponsor: GEMINI LABS LLC · Approved 1997-12-22

Drug application

FDA Application #

NDA020741

Application type

New Drug Application

Brand name

PRANDIN

Generic name

Repaglinide

Active ingredients

REPAGLINIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

GEMINI LABS LLC

First approval

1997-12-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown